(Surgery for Obesity and Related Diseases, 2023) reported mean weight loss of approximately 10-12% with semaglutide in post-bariatric patients over 612 months, though results varied considerably between individuals
Cautions: If you have sensitive or allergic skin, please do skin testing before use
AEDG peptide (Epitalon) stimulates gene expression and protein synthesis during neurogenesis: Possible epigenetic mechanism
Sources: November 6, 2025 White House fact sheet and manufacturer press releases To learn about GLP-1s, see our article, New Drugs for Weight Loss: What Plan Sponsors Need to Know. It appears that the TrumpRx prescription drug website, expected to be launched in early 2026, will link to the manufacturer DTC websites to allow purchase of the medications
Many experienced researchers recommend using bacteriostatic water mixing guides to create lower concentrations that are easier to measure precisely
Researchers compared change in body weight and metabolic outcomes for adults who used an obesity medication before receiving semaglutide with adults who did not use another obesity medication in the past